Everest by Log10 is an agentic AI platform for life sciences that powers regulatory, clinical, and commercial workflows for pharmaceutical companies, medtech firms, and CROs. The platform turns source files into submission-ready documents in minutes, generating not just the document but the underlying statistical analysis including TLFs and reproducible R and SAS code. Everest supports every phase of clinical trials from study startup through regulatory submission, handling protocols, investigator brochures, clinical study reports, and drug applications. The platform is SOC 2 Type II and HIPAA compliant with zero data retention from LLM providers, offering enterprise-grade security with optional VPC deployment and enhanced data isolation. Founded in 2023, headquartered in San Francisco, United States, The company has raised $7.2M at the Seed stage, backed by investors including TQ Ventures, Quiet Capital, Essence VC..
← All startups
Log10
SeedEverest by Log10 is an agentic AI platform for life sciences that powers regulatory, clinical, and commercial workflows for pharmaceutical companies, medtech firms, and CROs. The platform turns source files into submission-ready documents in minutes, generating not just the document but the underlying statistical analysis including TLFs and reproducible R and SAS code. Everest supports every phase of clinical trials…
About
Team background
Company Wise > Intel
Institutional investors
TQ VenturesQuiet CapitalEssence VC
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Explore Life Sciences investors — funds that write checks in this sector.